December 06, 2016
Kadmon Presents Encouraging Data on Tesevatinib in EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases and/or Leptomeningeal Metastases
December 05, 2016
Kadmon Submits Abbreviated New Drug Application Filing for Trientine Hydrochloride to FDA
November 28, 2016
Kadmon to Present at the 28th Annual Piper Jaffray Healthcare Conference
View and download our company filings.
View our latest investor presentations, webcasts and events calendar.
We are committed to maintaining ongoing, open dialogue with the investor community. Explore financial news, investor events, press releases and contact information here.
Learn more about investing in our growth.
Receive press releases, SEC filings and more.
Subscribe to alerts
Kadmon Corporation, LLC
Copyright 2017. All Rights Reserved.